The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside

Virology

Volumn 479-480, Issue , 2015, Pages 568-577

  Liu, XueQiao ^a   Cohen, Jeffrey I ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Akt; Cytomegalovirus; Epstein Barr virus; Herpes simplex; Herpesvirus; Kaposi's sarcoma associated herpesvirus; PI3K; Varicella zoster

Indexed keywords

ANTIVIRUS AGENT; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; VIRUS PROTEIN;

ANTAGONISTS AND INHIBITORS; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VIRUS LATENCY; VIRUS REPLICATION;

ANTIVIRAL AGENTS; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84934291900     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.02.040     Document Type: Review

References (150)

1. Abboud E.R., Shelby B.D., Angelova M., Nelson A.B., Ferris M., McFerrin H.E., Morris C.A., Sullivan D.E. Kaposi sarcoma-associated herpesvirus g protein-coupled receptor enhances endothelial cell survival in part by upregulation of bcl-2. Ochsner J. 2013, 13:66-75.
2. Alsayed Y., Leleu X., Leontovich A., Oton A.B., Melhem M., George D., Ghobrial I.M. Proteomics analysis in post-transplant lymphoproliferative disorders. Eur. J. Haematol. 2008, 81:298-303.
3. Alwine J.C. Modulation of host cell stress responses by human cytomegalovirus. Curr. Top. Microbiol. Immunol. 2008, 325:263-279.
4. Andjelkovic M., Jakubowicz T., Cron P., Ming X.F., Han J.W., Hemmings B.A. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. USA 1996, 93:5699-5704.
5. Andreoni K.A., Wang X., Huang S.M., Huang E.S. Human cytomegalovirus hyperimmune globulin not only neutralizes HCMV infectivity, but also inhibits HCMV-induced intracellular NF-kappaB, Sp1, and PI3-K signaling pathways. J. Med. Virol. 2002, 67:33-40.
6. Angulo I., Vadas O., Garcon F., Banham-Hall E., Plagnol V., Leahy T.R., Baxendale H., Coulter T., Curtis J., Wu C., Blake-Palmer K., Perisic O., Smyth D., Maes M., Fiddler C., Juss J., Cilliers D., Markelj G., Chandra A., Farmer G., Kielkowska A., Clark J., Kracker S., Debre M., Picard C., Pellier I., Jabado N., Morris J.A., Barcenas-Morales G., Fischer A., Stephens L., Hawkins P., Barrett J.C., Abinun M., Clatworthy M., Durandy A., Doffinger R., Chilvers E.R., Cant A.J., Kumararatne D., Okkenhaug K., Williams R.L., Condliffe A., Nejentsev S. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science 2013, 342:866-871.
7. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind J.S., Asch A.S., Cesarman E., Gershengorn M.C., Mesri E.A. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998, 391:86-89.
8. Balakrishnan A., Chaillet J.R. Role of the inositol polyphosphate-4-phosphatase type II Inpp4b in the generation of ovarian teratomas. Dev. Biol. 2013, 373:118-129.
9. Barel M., Balbo M., Le Romancer M., Frade R. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively. Eur. J. Immunol. 2003, 33:2557-2566.
10. Bauer T.M., Patel M.R., Infante J.R. Targeting PI3 kinase in cancer. Pharmacol. Ther. 2015, 146:53-60.
11. Benetti L., Roizman B. Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1. J. Virol. 2006, 80:3341-3348.
12. Bertucci M.C., Mitchell C.A. Phosphoinositide 3-kinase and INPP4B in human breast cancer. Ann. N. Y. Acad. Sci. 2013, 1280:1-5.
13. Bhatt A.P., Bhende P.M., Sin S.H., Roy D., Dittmer D.P., Damania B. Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas. Blood 2010, 115:4455-4463.
14. Bhatt A.P., Damania B. AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV. Front. Immunol. 2012, 3:401.
15. Blachly J.S., Baiocchi R.A. Targeting PI3-kinase (PI3K), AKT and mTOR axis in lymphoma. Br. J. Haematol. 2014, 167:19-32.
16. Boratynska M., Smolska D. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders. Transpl. Int.: Off. J. Eur. Soc. Organ Transplant. 2008, 21:605-608.
17. Brinkmann M.M., Schulz T.F. Regulation of intracellular signalling by the terminal membrane proteins of members of the gammaherpesvirinae. J. Gen. Virol. 2006, 87:1047-1074.
18. Brognard J., Sierecki E., Gao T., Newton A.C. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol. Cell 2007, 25:917-931.
19. Buchkovich N.J., Yu Y., Zampieri C.A., Alwine J.C. The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat. Rev. Microbiol. 2008, 6:266-275.
20. Cai L.M., Lyu X.M., Luo W.R., Cui X.F., Ye Y.F., Yuan C.C., Peng Q.X., Wu D.H., Liu T.F., Wang E., Marincola F.M., Yao K.T., Fang W.Y., Cai H.B., Li X. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 2014, 341:11-14.
21. Camarena V., Kobayashi M., Kim J.Y., Roehm P., Perez R., Gardner J., Wilson A.C., Mohr I., Chao M.V. Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons. Cell Host Microbe 2010, 8:320-330.
22. Campistol J.M., Schena F.P. Kaposi's sarcoma in renal transplant recipients-the impact of proliferation signal inhibitors. Nephrol. Dial. Transplant.: Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 2007, 22(1):i17-i22.
23. Cannon M.L., Cesarman E. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene 2004, 23:514-523.
24. Cen O., Longnecker R. Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma. Mol. Cancer Ther. 2011, 10:679-686.
25. Chakraborty S., ValiyaVeettil M., Sadagopan S., Paudel N., Chandran B. c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells. J. Virol. 2011, 85:12410-12430.
26. Chan G., Nogalski M.T., Bentz G.L., Smith M.S., Parmater A., Yurochko A.D. PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes. J. Immunol. 2010, 184:3213-3222.
27. Chen J. Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications. World J. Virol. 2012, 1:154-161.
28. Chen Y.R., Liu M.T., Chang Y.T., Wu C.C., Hu C.Y., Chen J.Y. Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells. J. Virol. 2008, 82:8124-8137.
29. Cheshenko N., Liu W., Satlin L.M., Herold B.C. Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry. Mol. Biol. Cell 2007, 18:3119-3130.
30. Cheshenko N., Trepanier J.B., Gonzalez P.A., Eugenin E.A., Jacobs W.R., Herold B.C. Herpes simplex virus type 2 glycoprotein H interacts with integrin alphavbeta3 to facilitate viral entry and calcium signaling in human genital tract epithelial cells. J. Virol. 2014, 88:10026-10038.
31. Cheshenko N., Trepanier J.B., Stefanidou M., Buckley N., Gonzalez P., Jacobs W., Herold B.C. HSV activates Akt to trigger calcium release and promote viral entry: novel candidate target for treatment and suppression. FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol. 2013, 27:2584-2599.
32. Chiou S.H., Yang Y.P., Lin J.C., Hsu C.H., Jhang H.C., Yang Y.T., Lee C.H., Ho L.L., Hsu W.M., Ku H.H., Chen S.J., Chen S.S., Chang M.D., Wu C.W., Juan L.J. The immediate early 2 protein of human cytomegalovirus (HCMV) mediates the apoptotic control in HCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression. J. Immunol. 2006, 177:6199-6206.
33. Chuluunbaatar U., Roller R., Feldman M.E., Brown S., Shokat K.M., Mohr I. Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication. Genes Dev. 2010, 24:2627-2639.
34. Chung T.D., Wymer J.P., Smith C.C., Kulka M., Aurelian L. Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10). J. Virol. 1989, 63:3389-3398.
35. Cobbs C., Khan S., Matlaf L., McAllister S., Zider A., Yount G., Rahlin K., Harkins L., Bezrookove V., Singer E., Soroceanu L. HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation. Oncotarget 2014, 5:1091-1100.
36. Cobbs C.S., Soroceanu L., Denham S., Zhang W., Kraus M.H. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. Cancer Res. 2008, 68:724-730.
37. Cooray S. The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 2004, 85:1065-1076.
38. Crank M.C., Grossman J.K., Moir S., Pittaluga S., Buckner C.M., Kardava L., Agharahimi A., Meuwissen H., Stoddard J., Niemela J., Kuehn H., Rosenzweig S.D. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J. Clin. Immunol. 2014, 34:272-276.
39. Cuevas B.D., Lu Y., Mao M., Zhang J., LaPushin R., Siminovitch K., Mills G.B. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 2001, 276:27455-27461.
40. Darr C.D., Mauser A., Kenney S. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J. Virol. 2001, 75:6135-6142.
41. Dawson C.W., Tramountanis G., Eliopoulos A.G., Young L.S. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 2003, 278:3694-3704.
42. Deau M.C., Heurtier L., Frange P., Suarez F., Bole-Feysot C., Nitschke P., Cavazzana M., Picard C., Durandy A., Fischer A., Kracker S. A human immunodeficiency caused by mutations in the PIK3R1 gene. J. Clin. Investig. 2014, 124:3923-3928.
43. Diehl N., Schaal H. Make yourself at home: viral hijacking of the PI3K/Akt signaling pathway. Viruses 2013, 5:3192-3212.
44. Dufour F., Sasseville A.M., Chabaud S., Massie B., Siegel R.M., Langelier Y. The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFalpha- and FasL-induced apoptosis by interacting with caspase-8. Apoptosis 2011, 16:256-271.
45. Dunn E.F., Connor J.H. HijAkt: the PI3K/Akt pathway in virus replication and pathogenesis. Prog. Mol. Biol. Transl. Sci. 2012, 106:223-250.
46. Eaton H.E., Saffran H.A., Wu F.W., Quach K., Smiley J.R. Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity. J. Virol. 2014, 88:7379-7388.
47. Eliopoulos A.G., Young L.S. LMP1 structure and signal transduction. Semin. Cancer Biol. 2001, 11:435-444.
48. Engelman J.A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 2009, 9:550-562.
49. Feng W.H., Cohen J.I., Fischer S., Li L., Sneller M., Goldbach-Mansky R., Raab-Traub N., Delecluse H.J., Kenney S.C. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J. Natl. Cancer Inst. 2004, 96:1691-1702.
50. Fotheringham J.A., Coalson N.E., Raab-Traub N. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through alphav-integrin membrane translocation. J. Virol. 2012, 86:10308-10320.
51. Fukuda M., Longnecker R. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J. Virol. 2007, 81:9299-9306.
52. Furman R.R., Sharman J.P., Coutre S.E., Cheson B.D., Pagel J.M., Hillmen P., Barrientos J.C., Zelenetz A.D., Kipps T.J., Flinn I., Ghia P., Eradat H., Ervin T., Lamanna N., Coiffier B., Pettitt A.R., Ma S., Stilgenbauer S., Cramer P., Aiello M., Johnson D.M., Miller L.L., Li D., Jahn T.M., Dansey R.D., Hallek M., O'Brien S.M. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 2014, 370:997-1007.
53. Furukawa S., Wei L., Krams S.M., Esquivel C.O., Martinez O.M. PI3Kdelta inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas. Am. J. Transplant.: Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 2013, 13:2035-2043.
54. Gewinner C., Wang Z.C., Richardson A., Teruya-Feldstein J., Etemadmoghadam D., Bowtell D., Barretina J., Lin W.M., Rameh L., Salmena L., Pandolfi P.P., Cantley L.C. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer cell 2009, 16:115-125.
55. Gonnella R., Santarelli R., Farina A., Granato M., D'Orazi G., Faggioni A., Cirone M. Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line. J. Exp. Clin. Cancer Res.: CR 2013, 32:79.
56. Gopal A.K., Kahl B.S., de Vos S., Wagner-Johnston N.D., Schuster S.J., Jurczak W.J., Flinn I.W., Flowers C.R., Martin P., Viardot A., Blum K.A., Goy A.H., Davies A.J., Zinzani P.L., Dreyling M., Johnson D., Miller L.L., Holes L., Li D., Dansey R.D., Godfrey W.R., Salles G.A. PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma. New Engl. J. Med. 2014, 370:1008-1018.
57. Goswami R., Gershburg S., Satorius A., Gershburg E. Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus. Antiviral Res. 2012, 96:296-304.
58. Hartman H.N., Niemela J., Hintermeyer M.K., Garofalo M., Stoddard J., Verbsky J.W., Rosenzweig S.D., Routes J.M. Gain of function mutations of PIK3CD as a cause of primary sclerosing cholangitis. J. Clin. Immunol. 2014, 35:11-14.
59. Hassan B., Akcakanat A., Holder A.M., Meric-Bernstam F. Targeting the PI3-kinase/Akt/mTOR signaling pathway. Surg. Oncol. Clin. N. Am. 2013, 22:641-664.
60. Hatton O., Phillips L.K., Vaysberg M., Hurwich J., Krams S.M., Martinez O.M. Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas. J. Biol. Chem. 2011, 286:37368-37378.
61. Hemmings B.A., Restuccia D.F. PI3K-PKB/Akt pathway. Cold Spring Harb. Perspect. Biol. 2012, 4:1-4.
62. Hsu M.J., Wu C.Y., Chiang H.H., Lai Y.L., Hung S.L. PI3K/Akt signaling mediated apoptosis blockage and viral gene expression in oral epithelial cells during herpes simplex virus infection. Virus Res. 2010, 153:36-43.
63. Iwakiri D., Takada K. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. J Immunol. 2004, 172:1561-1566.
64. Johnson R.A., Wang X., Ma X.L., Huong S.M., Huang E.S. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 2001, 75:6022-6032.
65. Kati S., Tsao E.H., Gunther T., Weidner-Glunde M., Rothamel T., Grundhoff A., Kellam P., Schulz T.F. Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. J. Virol. 2013, 87:8004-8016.
66. Kerur N., Veettil M.V., Sharma-Walia N., Sadagopan S., Bottero V., Paul A.G., Chandran B. Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling. Virology 2010, 406:103-116.
67. Kim J.H., Kim W.S., Park C. Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1. Leuk. Lymphoma 2012, 53:1586-1591.
68. Kracker S., Curtis J., Ibrahim M.A., Sediva A., Salisbury J., Campr V., Debre M., Edgar J.D., Imai K., Picard C., Casanova J.L., Fischer A., Nejentsev S., Durandy A. Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome. J. Allergy Clin. Immunol. 2014, 134:233-236.
69. Krishnan H.H., Sharma-Walia N., Streblow D.N., Naranatt P.P., Chandran B. Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells. J. Virol. 2006, 80:1167-1180.
70. Kuo Y.C., Huang K.Y., Yang C.H., Yang Y.S., Lee W.Y., Chiang C.W. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J. Biol. Chem. 2008, 283:1882-1892.
71. Laing J.M., Golembewski E.K., Wales S.Q., Liu J., Jafri M.S., Yarowsky P.J., Aurelian L. Growth-compromised HSV-2 vector Delta RR protects from N-methyl-D-aspartate-induced neuronal degeneration through redundant activation of the MEK/ERK and PI3-K/Akt survival pathways, either one of which overrides apoptotic cascades. J. Neurosci. Res. 2008, 86:378-391.
72. Laing J.M., Smith C.C., Aurelian L. Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine. J. Neurochem. 2010, 112:662-676.
73. Lam N., Sugden B. CD40 and its viral mimic, LMP1: similar means to different ends. Cell Signal 2003, 15:9-16.
74. Lambert S.L., Martinez O.M. Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10. J Immunol. 2007, 179:8225-8234.
75. Lebbe C., Euvrard S., Barrou B., Pouteil-Noble C., Garnier J.L., Glotz D., Legendre C., Frances C. Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am. J. Transplant.: Off J. Am. Soc. Transplant. Am. Soc. Transpl. Surg. 2006, 6:2164-2168.
76. Li S., Carpenter D., Hsiang C., Wechsler S.L., Jones C. Herpes simplex virus type 1 latency-associated transcript inhibits apoptosis and promotes neurite sprouting in neuroblastoma cells following serum starvation by maintaining protein kinase B (AKT) levels. J. Gen. Virol. 2010, 91:858-866.
77. Li S.S., Yang S., Wang S., Yang X.M., Tang Q.L., Wang S.H. Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway. Oncol. Rep. 2011, 26:1573-1579.
78. Li X., Chen S., Sun R. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2012, 86:6668-6676.
79. Liu X., Cohen J.I. Varicella-zoster virus ORF12 protein activates the phosphatidylinositol 3-kinase/Akt pathway to regulate cell cycle progression. J. Virol. 2013, 87:1842-1848.
80. Lucas C.L., Kuehn H.S., Zhao F., Niemela J.E., Deenick E.K., Palendira U., Avery D.T., Moens L., Cannons J.L., Biancalana M., Stoddard J., Ouyang W., Frucht D.M., Rao V.K., Atkinson T.P., Agharahimi A., Hussey A.A., Folio L.R., Olivier K.N., Fleisher T.A., Pittaluga S., Holland S.M., Cohen J.I., Oliveira J.B., Tangye S.G., Schwartzberg P.L., Lenardo M.J., Uzel G. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat. Immunol. 2014, 15:88-97.
81. Lucas C.L., Zhang Y., Venida A., Wang Y., Hughes J., McElwee J., Butrick M., Matthews H., Price S., Biancalana M., Wang X., Richards M., Pozos T., Barlan I., Ozen A., Rao V.K., Su H.C., Lenardo M.J. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J. Exp. Med. 2014, 211:2537-2547.
82. MacLeod I.J., Minson T. Binding of herpes simplex virus type-1 virions leads to the induction of intracellular signalling in the absence of virus entry. PLoS One 2010, 5:e9560.
83. Mainou B.A., Everly D.N., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 2005, 24:6917-6924.
84. Mainou B.A., Everly D.N., Raab-Traub N. Unique signaling properties of CTAR1 in LMP1-mediated transformation. J. Virol. 2007, 81:9680-9692.
85. Matskova L.V., Helmstetter C., Ingham R.J., Gish G., Lindholm C.K., Ernberg I., Pawson T., Winberg G. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein. Oncogene 2007, 26:4908-4917.
86. McFarlane S., Nicholl M.J., Sutherland J.S., Preston C.M. Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha. Virology 2011, 414:83-90.
87. Montaner S., Sodhi A., Pece S., Mesri E.A., Gutkind J.S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res. 2001, 61:2641-2648.
88. Moody C.A., Scott R.S., Amirghahari N., Nathan C.O., Young L.S., Dawson C.W., Sixbey J.W. Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A. J. Virol. 2005, 79:5499-5506.
89. Morris V.A., Punjabi A.S., Lagunoff M. Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells. J. Virol. 2008, 82:8771-8779.
90. Morris V.A., Punjabi A.S., Wells R.C., Wittkopp C.J., Vart R., Lagunoff M. The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. Virology 2012, 428:112-120.
91. Morrison J.A., Klingelhutz A.J., Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J. Virol. 2003, 77:12276-12284.
92. Morrison J.A., Raab-Traub N. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling. J. Virol. 2005, 79:2375-2382.
93. Munoz-Fontela C., Collado M., Rodriguez E., Garcia M.A., Alvarez-Barrientos A., Arroyo J., Nombela C., Rivas C. Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus. Exp. Cell Res. 2005, 311:96-105.
94. Naghavi M.H., Gundersen G.G., Walsh D. Plus-end tracking proteins, CLASPs, and a viral Akt mimic regulate herpesvirus-induced stable microtubule formation and virus spread. Proc. Natl. Acad. Sci. USA 2013, 110:18268-18273.
95. Naranatt P.P., Akula S.M., Zien C.A., Krishnan H.H., Chandran B. Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J. Virol. 2003, 77:1524-1539.
96. Nepomuceno R.R., Balatoni C.E., Natkunam Y., Snow A.L., Krams S.M., Martinez O.M. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. Cancer Res. 2003, 63:4472-4480.
97. Nicola A.V., Straus S.E. Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J. Virol. 2004, 78:7508-7517.
98. Okkenhaug K. Signaling by the phosphoinositide 3-kinase family in immune cells. Annu. Rev. Immunol. 2013, 31:675-704.
99. Oussaief L., Hippocrate A., Ramirez V., Rampanou A., Zhang W., Meyers D., Cole P., Khelifa R., Joab I. Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation. J. Biol. Chem. 2009, 284:23912-23924.
100. Parry C., Bell S., Minson T., Browne H. Herpes simplex virus type 1 glycoprotein H binds to alphavbeta3 integrins. J. Gen. Virol. 2005, 86:7-10.
101. Pascual J. Post-transplant lymphoproliferative disorder - the potential of proliferation signal inhibitors. Nephrol. Dial Transplant.: Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 2007, 22(1):i27-i35.
102. Pati S., Foulke J.S., Barabitskaya O., Kim J., Nair B.C., Hone D., Smart J., Feldman R.A., Reitz M. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J. Virol. 2003, 77:5759-5773.
103. Peng L., Wu T.T., Tchieu J.H., Feng J., Brown H.J., Feng J., Li X., Qi J., Deng H., Vivanco I., Mellinghoff I.K., Jamieson C., Sun R. Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency. J. Gen. Virol. 2010, 91:463-469.
104. Perez-Tenorio G., Alkhori L., Olsson B., Waltersson M.A., Nordenskjold B., Rutqvist L.E., Skoog L., Stal O. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer. Clin. Cancer Res. 2007, 13:3577-3584.
105. Perkins D., Pereira E.F., Gober M., Yarowsky P.J., Aurelian L. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 2002, 76:1435-1449.
106. Perkins D., Yu Y., Bambrick L.L., Yarowsky P.J., Aurelian L. Expression of herpes simplex virus type 2 protein ICP10 PK rescues neurons from apoptosis due to serum deprivation or genetic defects. Exp. Neurol. 2002, 174:118-122.
107. Portis T., Longnecker R. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 2004, 23:8619-8628.
108. Prakash O., Swamy O.R., Peng X., Tang Z.Y., Li L., Larson J.E., Cohen J.C., Gill J., Farr G., Wang S., Samaniego F. Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis. Blood 2005, 105:3987-3994.
109. Rahaus M., Desloges N., Wolff M.H. Varicella-zoster virus requires a functional PI3K/Akt/GSK-3alpha/beta signaling cascade for efficient replication. Cell Signal 2007, 19:312-320.
110. Ruggeri B.A., Huang L., Wood M., Cheng J.Q., Testa J.R. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas. Mol. Carcinog. 1998, 21:81-86.
111. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S.M., Riggins G.J., Willson J.K., Markowitz S., Kinzler K.W., Vogelstein B., Velculescu V.E. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004, 304:554.
112. Scholle F., Bendt K.M., Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 2000, 74:10681-10689.
113. Sen N., Mukherjee G., Sen A., Bendall S.C., Sung P., Nolan G.P., Arvin A.M. Single-cell mass cytometry analysis of human tonsil T cell remodeling by varicella zoster virus. Cell Rep. 2014, 8:633-645.
114. Shair K.H., Bendt K.M., Edwards R.H., Bedford E.C., Nielsen J.N., Raab-Traub N. EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas. PLoS Pathog. 2007, 3:e166.
115. Shair K.H., Schnegg C.I., Raab-Traub N. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res. 2008, 68:6997-7005.
116. Sharma-Walia N., Naranatt P.P., Krishnan H.H., Zeng L., Chandran B. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J. Virol. 2004, 78:4207-4223.
117. Sharma-Walia N., Patel K., Chandran K., Marginean A., Bottero V., Kerur N., Paul A.G. COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP. Oncogenesis 2012, 1:e5.
118. Sin S.H., Roy D., Wang L., Staudt M.R., Fakhari F.D., Patel D.D., Henry D., Harrington W.J., Damania B.A., Dittmer D.P. Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. Blood 2007, 109:2165-2173.
119. Smit M.J., Verzijl D., Casarosa P., Navis M., Timmerman H., Leurs R. Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J. Virol. 2002, 76:1744-1752.
120. Smith C.C. The herpes simplex virus type 2 protein ICP10PK: a master of versatility. Front. Biosci.: J. Virtual Libr. 2005, 10:2820-2831.
121. Sodhi A., Chaisuparat R., Hu J., Ramsdell A.K., Manning B.D., Sausville E.A., Sawai E.T., Molinolo A., Gutkind J.S., Montaner S. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 2006, 10:133-143.
122. Sodhi A., Montaner S., Patel V., Gomez-Roman J.J., Li Y., Sausville E.A., Sawai E.T., Gutkind J.S. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc. Natl. Acad. Sci. USA 2004, 101:4821-4826.
123. Soni V., Cahir-McFarland E., Kieff E. LMP1 TRAFficking activates growth and survival pathways. Adv. Exp. Med. Biol. 2007, 597:173-187.
124. Soroceanu L., Akhavan A., Cobbs C.S. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 2008, 455:391-395.
125. Spender L.C., Lucchesi W., Bodelon G., Bilancio A., Karstegl C.E., Asano T., Dittrich-Breiholz O., Kracht M., Vanhaesebroeck B., Farrell P.J. Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. J. Gen. Virol. 2006, 87:2859-2867.
126. Staal S.P. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. USA 1987, 84:5034-5037.
127. Stallone G., Schena A., Infante B., Di Paolo S., Loverre A., Maggio G., Ranieri E., Gesualdo L., Schena F.P., Grandaliano G. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. New Engl. J. Med. 2005, 352:1317-1323.
128. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998, 95:29-39.
129. Strunk U., Saffran H.A., Wu F.W., Smiley J.R. Role of herpes simplex virus VP11/12 tyrosine-based motifs in binding and activation of the Src family kinase Lck and recruitment of p85, Grb2, and Shc. J. Virol. 2013, 87:11276-11286.
130. Swart R., Ruf I.K., Sample J., Longnecker R. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J. Virol. 2000, 74:10838-10845.
131. Tasian S.K., Teachey D.T., Rheingold S.R. Targeting the PI3K/mTOR pathway in pediatric hematologic malignancies. Front. Oncol. 2014, 4:108.
132. Tiwari V., Shukla D. Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry. J Gen Virol. 2010, 91:3002-3009.
133. Tomlinson C.C., Damania B. The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J. Virol. 2004, 78:1918-1927.
134. Tsalikis J., Croitoru D.O., Philpott D.J., Girardin S.E. Nutrient sensing and metabolic stress pathways in innate immunity. Cell Microbiol. 2013, 15:1632-1641.
135. Tsuruta F., Masuyama N., Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 2002, 277:14040-14047.
136. Uddin S., Hussain A.R., Al-Hussein K.A., Manogaran P.S., Wickrema A., Gutierrez M.I., Bhatia K.G. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Clin. Cancer Res. 2005, 11:3102-3108.
137. Valiya Veettil M., Sadagopan S., Kerur N., Chakraborty S., Chandran B. Interaction of c-Cbl with myosin IIA regulates Bleb associated macropinocytosis of Kaposi's sarcoma-associated herpesvirus. PLoS Pathog. 2010, 6:e1001238.
138. Vanhaesebroeck B., Stephens L., Hawkins P. PI3K signalling: the path to discovery and understanding. Nat. Rev. Mol. Cell Biol. 2012, 13:195-203.
139. Veettil M.V., Sharma-Walia N., Sadagopan S., Raghu H., Sivakumar R., Naranatt P.P., Chandran B. RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J. Virol. 2006, 80:11432-11446.
140. Wagner M.J., Smiley J.R. Herpes simplex virus requires VP11/12 to activate Src family kinase-phosphoinositide 3-kinase-Akt signaling. J. Virol. 2011, 85:2803-2812.
141. Walsh D., Mohr I. Viral subversion of the host protein synthesis machinery. Nat. Rev. Microbiol. 2011, 9:860-875.
142. Wang L., Damania B. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res. 2008, 68:4640-4648.
143. Wang L., Dittmer D.P., Tomlinson C.C., Fakhari F.D., Damania B. Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res. 2006, 66:3658-3666.
144. Wlodarski P., Kasprzycka M., Liu X., Marzec M., Robertson E.S., Slupianek A., Wasik M.A. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res. 2005, 65:7800-7808.
145. Xue M., Yao S., Hu M., Li W., Hao T., Zhou F., Zhu X., Lu H., Qin D., Yan Q., Zhu J., Gao S.J., Lu C. HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway. Nucleic Acids Res. 2014, 42:9862-9879.
146. Yang G.D., Huang T.J., Peng L.X., Yang C.F., Liu R.Y., Huang H.B., Chu Q.Q., Yang H.J., Huang J.L., Zhu Z.Y., Qian C.N., Huang B.J. Epstein-Barr virus encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L. PLoS One 2013, 8:e78355.
147. Yu Y., Alwine J.C. Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3'-OH kinase pathway and the cellular kinase Akt. J. Virol. 2002, 76:3731-3738.
148. Yuen J.W., Chung G.T., Lun S.W., Cheung C.C., To K.F., Lo K.W. Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma. PLoS One 2014, 9:e105163.
149. Zhang X., Wang J.F., Chandran B., Persaud K., Pytowski B., Fingeroth J., Groopman J.E. Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection. J. Biol. Chem. 2005, 280:26216-26224.
150. Zheng K., Xiang Y., Wang X., Wang Q., Zhong M., Wang S., Wang X., Fan J., Kitazato K., Wang Y. Epidermal growth factor receptor-PI3K signaling controls cofilin activity to facilitate herpes simplex virus 1 entry into neuronal cells. mBio 2014, 5:e00958-00913.